Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Université de Sherbrooke

$24,493.00

Implementing a vibrating element on a medical cutting device for percutaneous aortic valve replacement - Implantation d'un élément vibrant pour le remplacement valvulaire aortique

EF 2011-12

Résumé
Bavaria Medical Technology, Canada Inc. is developing the CutCath, a percutaneous site preparation device used to cut through calcified heart valve leaflets in order to enhance the apposition of prosthetic valves. However, by combining the cutting element in the CutCath with ultrasound, the energy requirement may be lowered. It is hypothesized that using these vibrations would help cut through a densely calcified valve without applying great strain on the heart. The objective of the project is to design and build an ultrasonic apparatus prototype that can be combined with the CutCath cutting catheter in order to efficiently cut through calcified leaflet. In particular, we want to investigate methods to transmit ultrasonic vibrations through a catheter without injuring the patient or damaging other catheter bonds. Once this is achieved, we want to optimize these vibrations to produce a repeatable and efficient cut. We will build and test a prototype ultrasound-driven cutting catheter in the laboratory, and will validate the device using aortic valve phantoms. All relevant prototype documentation will be transferred to BMT-Canada at the end of the project for eventual engineering into a commercial device.
Programme
Engage Grants Program
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
413425-2011
Name nom
Brouillette, Martin
Department département
Génie mécanique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
24493
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Implementing a vibrating element on a medical cutting device for percutaneous aortic valve replacement - Implantation d'un élément vibrant pour le remplacement valvulaire aortique
Keyword
NSERC
Application summary
Bavaria Medical Technology, Canada Inc. is developing the CutCath, a percutaneous site preparation device used to cut through calcified heart valve leaflets in order to enhance the apposition of prosthetic valves. However, by combining the cutting element in the CutCath with ultrasound, the energy requirement may be lowered. It is hypothesized that using these vibrations would help cut through a densely calcified valve without applying great strain on the heart. The objective of the project is to design and build an ultrasonic apparatus prototype that can be combined with the CutCath cutting catheter in order to efficiently cut through calcified leaflet. In particular, we want to investigate methods to transmit ultrasonic vibrations through a catheter without injuring the patient or damaging other catheter bonds. Once this is achieved, we want to optimize these vibrations to produce a repeatable and efficient cut. We will build and test a prototype ultrasound-driven cutting catheter in the laboratory, and will validate the device using aortic valve phantoms. All relevant prototype documentation will be transferred to BMT-Canada at the end of the project for eventual engineering into a commercial device.